Search

Your search keyword '"Hinkel Gk"' showing total 14 results
Start Over Author "Hinkel Gk" Topic infant, premature, diseases
14 results on '"Hinkel Gk"'

1. [Esophageal complications in tracheotomied premature infants].

Author

Probsthain AR and Hinkel GK

Subjects
Female, Humans, Infant, Infant, Newborn, Infant, Premature, Infant, Premature, Diseases surgery, Male, Tracheal Stenosis surgery, Infant, Premature, Diseases etiology, Tracheoesophageal Fistula etiology, Tracheotomy adverse effects
Published
1976

2. [Soor prevention in premature infants. I. Effectiveness of nystatin in healthy newborn infants].

Author

Schwarze R, Blaschke-Hellmessen R, Hinkel GK, Hoffmann H, and Weigl I

Subjects
Age Factors, Candidiasis, Cutaneous prevention & control, Candidiasis, Oral prevention & control, Humans, Infant, Infant, Newborn, Mouth Diseases prevention & control, Rectum microbiology, Skin microbiology, Candidiasis prevention & control, Infant, Newborn, Diseases prevention & control, Infant, Premature, Diseases prevention & control, Nystatin therapeutic use
Published
1976

4. An enzyme inductor combination for the prevention of hyperbilirubinemia in premature infants.

Author

Hinkel GK, Kintzel HW, Schwarze R, and Händel A

Subjects
Administration, Oral, Bilirubin blood, Depression, Chemical, Dose-Response Relationship, Drug, Drug Therapy, Combination, Enzyme Induction drug effects, Humans, Infant, Newborn, Jaundice, Neonatal drug therapy, Nikethamide administration & dosage, Nikethamide pharmacology, Phenobarbital administration & dosage, Phenobarbital pharmacology, Time Factors, Infant, Premature, Diseases prevention & control, Jaundice, Neonatal prevention & control, Nikethamide therapeutic use, Phenobarbital therapeutic use
Published
1974
Full Text
View/download PDF

5. [Candida albicans and other yeast contaminatedhuman milk as a cause of group infection in newborn infants].

Author

Kintzel HW, Hinkel GK, and Blaschke-Hellmessen R

Subjects
Breast, Breast Feeding, Candida albicans isolation & purification, Cross Infection, Female, Humans, Infant, Newborn, Mitosporic Fungi isolation & purification, Saccharomyces isolation & purification, Seasons, Skin microbiology, Candida isolation & purification, Candidiasis, Oral etiology, Food Contamination, Infant, Premature, Diseases etiology, Milk, Human microbiology
Published
1971

6. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].

Author

Kintzel HW, Schwarze R, and Hinkel GK

Subjects
Bilirubin blood, Exchange Transfusion, Whole Blood, Female, Humans, Infant, Newborn, Orotic Acid therapeutic use, Pregnancy, Rh-Hr Blood-Group System, Enzyme Induction, Erythroblastosis, Fetal prevention & control, Hyperbilirubinemia prevention & control, Infant, Newborn, Diseases prevention & control, Infant, Premature, Diseases prevention & control, Nikethamide therapeutic use, Phenobarbital therapeutic use
Published
1972

8. [The influence of combined therapy with orotic acid and phenobarbital on the level of serum bilirubin in premature infants].

Author

Hinkel GK, Schwarze R, and Kintzel HW

Subjects
Birth Weight, Drug Combinations, Drug Synergism, Humans, Infant, Newborn, Orotic Acid adverse effects, Orotic Acid therapeutic use, Phenobarbital adverse effects, Phenobarbital therapeutic use, Bilirubin blood, Infant, Premature, Diseases drug therapy, Jaundice, Neonatal drug therapy, Orotic Acid administration & dosage, Phenobarbital administration & dosage
Published
1972

12. [Prevention of hyperbilirubinemia in premature and newborn infants using orotic acid].

Author

Hinkel GK, Kintzel HW, and Schwarze R

Subjects
Enzyme Induction, Humans, Infant, Infant, Newborn, Infant, Premature, Intestinal Absorption, Jaundice, Neonatal prevention & control, Hyperbilirubinemia prevention & control, Infant, Newborn, Diseases prevention & control, Infant, Premature, Diseases prevention & control, Orotic Acid therapeutic use
Published
1972

14. An enzyme inductor combination for the prevention of hyperbilirubinemia in premature infants

Author

Kintzel Hw, R. Schwarze, Händel A, and Hinkel Gk

Subjects
Pediatrics, medicine.medical_specialty, Time Factors, Dose, medicine.medical_treatment, Nikethamide, Exchange transfusion, Administration, Oral, Infant, Premature, Diseases, Body weight, medicine, Humans, Neonatology, Cumulative effect, Dose-Response Relationship, Drug, business.industry, Infant, Newborn, Bilirubin, General Medicine, Jaundice, Neonatal, Regimen, Nicethamide, Anesthesia, Depression, Chemical, Enzyme Induction, Phenobarbital, Pediatrics, Perinatology and Child Health, Drug Therapy, Combination, business, medicine.drug
Abstract

Hinkel, G. K., Kintzel, H.-W., Schwarze, R. and Hiindel, A. (Paediatric Hospital, Medical Academy “Carl Gustav Carus”, Department of Neonatology, Dresden, GDR). Enzyme inductor combination to prevent hyperbilirubinaemia in premature infants. Acta Paediatr Scand, 63: 393, 1974.–In the management of physiologic hyperbilirubinemia in newborn infants, phenobarbital and nicethamide (diethylnicotinamide), as an enzyme inductor combination, are found to have a cumulative effect and, consequently, are clearly superior to the use of phenobarbital alone. Four different dosages were compared and the most favourable variant proved to be phenobarbital, 10 mg/kg body weight pro die from day 1 to day 3 (after birth), combined with nicethamide, 100 mg/kg per diem from day 1 to day 4. Exchange transfusion was no longer necessary in 400 premature infants who had received this type of prophylactic combination and thus the routine use of this inductor regimen can now be recommended.

Published
1974

Catalog

Books, media, physical & digital resources
See catalog results